Venous thromboembolism represents a major global health burden, affecting approximately 10 million individuals annually worldwide. The condition claims approximately 544,000 lives per year in Europe alone, with pulmonary embolism mortality rates reaching 30 percent when left untreated. In the United States, the disease affects up to 900,000 people annually, causing between 100,000 and 180,000 deaths per year.
These sobering statistics underscore the urgency of improved diagnostic methods. A newly developed PET radiotracer offers promise in addressing this public health challenge by enabling rapid, comprehensive detection of blood clots throughout the body. Early identification and treatment are critical to preventing fatal outcomes, and streamlining the diagnostic process through single-scan imaging technology could significantly improve survival rates.
Researchers presenting their findings at the 2026 SNMMI Annual Meeting demonstrate this innovative approach’s potential to transform clinical practice. Read the full article on GMJ Newsroom.
Was this article helpful?
